188 related articles for article (PubMed ID: 29978518)
21. CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model.
Lim JY; Ryu DB; Kim TW; Lee SE; Park G; Yoon HK; Min CK
Stem Cell Res Ther; 2020 Jun; 11(1):254. PubMed ID: 32586381
[TBL] [Abstract][Full Text] [Related]
22. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Kimura H; Date M; Hamaguchi Y; Hasegawa M; Hau KT; Fujimoto M; Takehara K; Matsushita T
J Dermatol Sci; 2014 Jun; 74(3):214-21. PubMed ID: 24679982
[TBL] [Abstract][Full Text] [Related]
23. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Tedder TF; Fujimoto M
Blood; 2013 Apr; 121(16):3274-83. PubMed ID: 23422748
[TBL] [Abstract][Full Text] [Related]
24. Effects of 5-aminolevulinic acid and sodium ferrous citrate on fibroblasts from individuals with mitochondrial diseases.
Shimura M; Nozawa N; Ogawa-Tominaga M; Fushimi T; Tajika M; Ichimoto K; Matsunaga A; Tsuruoka T; Kishita Y; Ishii T; Takahashi K; Tanaka T; Nakajima M; Okazaki Y; Ohtake A; Murayama K
Sci Rep; 2019 Jul; 9(1):10549. PubMed ID: 31332208
[TBL] [Abstract][Full Text] [Related]
25. 5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injury.
Hou J; Cai S; Kitajima Y; Fujino M; Ito H; Takahashi K; Abe F; Tanaka T; Ding Q; Li XK
Am J Physiol Renal Physiol; 2013 Oct; 305(8):F1149-57. PubMed ID: 23904222
[TBL] [Abstract][Full Text] [Related]
26. 5-aminolaevulinic acid (ALA), enhances heme oxygenase (HO)-1 expression and attenuates tubulointerstitial fibrosis and renal apoptosis in chronic cyclosporine nephropathy.
Liu C; Zhu P; Fujino M; Isaka Y; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhuang J; Li XK
Biochem Biophys Res Commun; 2019 Jan; 508(2):583-589. PubMed ID: 30514440
[TBL] [Abstract][Full Text] [Related]
27. 5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction.
Fujino M; Nishio Y; Ito H; Tanaka T; Li XK
Int Immunopharmacol; 2016 Aug; 37():71-78. PubMed ID: 26643355
[TBL] [Abstract][Full Text] [Related]
28. Absence of cutaneous TNFalpha-producing CD4+ T cells and TNFalpha may allow for fibrosis rather than epithelial cytotoxicity in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
Askew D; Zhou L; Wu C; Chen G; Gilliam AC
J Invest Dermatol; 2007 Aug; 127(8):1905-14. PubMed ID: 17429441
[TBL] [Abstract][Full Text] [Related]
29. 5-ALA/SFC Attenuated Binge Alcohol-Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats.
Liu C; Zhu P; Fujino M; Zhu S; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhuang J; Li XK
Alcohol Clin Exp Res; 2019 Aug; 43(8):1651-1661. PubMed ID: 31141180
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases-systemic sclerosis and sclerodermatous graft-versus-host disease.
Yang H; Cheong S; He Y; Lu F
Stem Cell Res Ther; 2023 Dec; 14(1):372. PubMed ID: 38111001
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model.
Lim JY; Ryu DB; Lee SE; Park G; Min CK
J Invest Dermatol; 2017 Sep; 137(9):1895-1904. PubMed ID: 28526296
[TBL] [Abstract][Full Text] [Related]
32. 5-aminolevulinic acid combined with ferrous ion reduces adiposity and improves glucose tolerance in diet-induced obese mice via enhancing mitochondrial function.
Ota U; Hara T; Nakagawa H; Tsuru E; Tsuda M; Kamiya A; Kuroda Y; Kitajima Y; Koda A; Ishizuka M; Fukuhara H; Inoue K; Shuin T; Nakajima M; Tanaka T
BMC Pharmacol Toxicol; 2017 Jan; 18(1):7. PubMed ID: 28132645
[TBL] [Abstract][Full Text] [Related]
33. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
[TBL] [Abstract][Full Text] [Related]
34. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
Huang J; Beyer C; Palumbo-Zerr K; Zhang Y; Ramming A; Distler A; Gelse K; Distler O; Schett G; Wollin L; Distler JH
Ann Rheum Dis; 2016 May; 75(5):883-90. PubMed ID: 25858641
[TBL] [Abstract][Full Text] [Related]
35. Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.
Ponsoye M; Frantz C; Ruzehaji N; Nicco C; Elhai M; Ruiz B; Cauvet A; Pezet S; Brandely ML; Batteux F; Allanore Y; Avouac J
Ann Rheum Dis; 2016 Dec; 75(12):2142-2149. PubMed ID: 26912566
[TBL] [Abstract][Full Text] [Related]
36. Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma.
Pines M; Snyder D; Yarkoni S; Nagler A
Biol Blood Marrow Transplant; 2003 Jul; 9(7):417-25. PubMed ID: 12869955
[TBL] [Abstract][Full Text] [Related]
37. 5-ALA/SFC enhances HO-1 expression through the MAPK/Nrf2 antioxidant pathway and attenuates murine tubular epithelial cell apoptosis.
Liu C; Fujino M; Zhu S; Isaka Y; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhu P; Li XK
FEBS Open Bio; 2019 Nov; 9(11):1928-1938. PubMed ID: 31495071
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis.
Negoro H; Chatziantonio C; Razzaque MS
Expert Rev Anti Infect Ther; 2022 May; 20(5):657-661. PubMed ID: 34927515
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of EGFR Tyrosine Kinase by Erlotinib Prevents Sclerodermatous Graft-Versus-Host Disease in a Mouse Model.
Morin F; Kavian N; Marut W; Chéreau C; Cerles O; Grange P; Weill B; Nicco C; Batteux F
J Invest Dermatol; 2015 Oct; 135(10):2385-2393. PubMed ID: 25938558
[TBL] [Abstract][Full Text] [Related]
40. 5-ALA/SFC Ameliorates Endotoxin-Induced Ocular Inflammation in Rats by Inhibiting the NF-κB Signaling Pathway and Activating the HO-1/Nrf2 Signaling Pathway.
Otaka Y; Kanai K; Mori A; Okada D; Nagai N; Yamashita Y; Ichikawa Y; Tajima K
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
